Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

797 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
End-stage kidney disease in Fiji.
Krishnan A, Chandra Y, Malani J, Jesudason S, Sen S, Ritchie AG. Krishnan A, et al. Among authors: ritchie ag. Intern Med J. 2019 Apr;49(4):461-466. doi: 10.1111/imj.14108. Intern Med J. 2019. PMID: 30230153
Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial.
Hockham C, Kotwal S, Wilcox A, Bassi A, McGree J, Pollock C, Burrell LM, Bathla N, Kunigari M, Rathore V, John M, Lin E, Jenkins C, Ritchie A, McLachlan A, Snelling T, Jones M, Jha V, Jardine M; CLARITY Investigators. Hockham C, et al. Among authors: ritchie a. Trials. 2021 Aug 28;22(1):573. doi: 10.1186/s13063-021-05521-0. Trials. 2021. PMID: 34454580 Free PMC article.
Global Dialysis Perspective: Fiji.
Talbot B; Fijian Dialysis Registry Collaboration. Talbot B, et al. Kidney360. 2021 Oct 26;3(1):164-167. doi: 10.34067/KID.0005652021. eCollection 2022 Jan 27. Kidney360. 2021. PMID: 35368567 Free PMC article. No abstract available.
Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial.
Jardine MJ, Kotwal SS, Bassi A, Hockham C, Jones M, Wilcox A, Pollock C, Burrell LM, McGree J, Rathore V, Jenkins CR, Gupta L, Ritchie A, Bangi A, D'Cruz S, McLachlan AJ, Finfer S, Cummins MM, Snelling T, Jha V; CLARITY trial investigators. Jardine MJ, et al. Among authors: ritchie a. BMJ. 2022 Nov 16;379:e072175. doi: 10.1136/bmj-2022-072175. BMJ. 2022. PMID: 36384746 Free PMC article. Clinical Trial.
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
797 results